On Zakaria's GPS on CNN today they were lauding a new sort of thermos that would keep vaccines cold in hot parts of the world. It's too bad they didn't talk about Novavax's capability, which doesn't require that vaccines be kept cold at all. I think NVAX should respond to the GPS show with a demonstration of its own product.
There have been many excelletn posts on the board describing how successful NVAX has been until now, but I don't believe anyone has noted the consistency of their success. As far as I can tell all goals have been achieved; remarkable for a biotech company. And as noted, Novavax is building to a remarkable future. Its RSV vaccine will be a pervasive and richly rewarded success.